KR20200017516A - 성적 기능장애의 치료 및 성적 삶의 질의 향상 - Google Patents

성적 기능장애의 치료 및 성적 삶의 질의 향상 Download PDF

Info

Publication number
KR20200017516A
KR20200017516A KR1020207001647A KR20207001647A KR20200017516A KR 20200017516 A KR20200017516 A KR 20200017516A KR 1020207001647 A KR1020207001647 A KR 1020207001647A KR 20207001647 A KR20207001647 A KR 20207001647A KR 20200017516 A KR20200017516 A KR 20200017516A
Authority
KR
South Korea
Prior art keywords
stem cells
mesenchymal stem
sexual
patient
administered
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1020207001647A
Other languages
English (en)
Korean (ko)
Inventor
다시 엘. 디페데
조슈아 엠. 하레
Original Assignee
롱에버론 엘엘씨
다시 엘. 디페데
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 롱에버론 엘엘씨, 다시 엘. 디페데 filed Critical 롱에버론 엘엘씨
Publication of KR20200017516A publication Critical patent/KR20200017516A/ko
Withdrawn legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/54—Ovaries; Ova; Ovules; Embryos; Foetal cells; Germ cells
    • A61K35/545—Embryonic stem cells; Pluripotent stem cells; Induced pluripotent stem cells; Uncharacterised stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Reproductive Health (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
KR1020207001647A 2017-06-19 2018-06-15 성적 기능장애의 치료 및 성적 삶의 질의 향상 Withdrawn KR20200017516A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762521765P 2017-06-19 2017-06-19
US62/521,765 2017-06-19
PCT/US2018/037725 WO2018236680A1 (en) 2017-06-19 2018-06-15 TREATMENT OF SEXUAL DYSFUNCTION AND IMPROVEMENT OF THE QUALITY OF SEXUAL LIFE

Publications (1)

Publication Number Publication Date
KR20200017516A true KR20200017516A (ko) 2020-02-18

Family

ID=62952383

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020207001647A Withdrawn KR20200017516A (ko) 2017-06-19 2018-06-15 성적 기능장애의 치료 및 성적 삶의 질의 향상

Country Status (12)

Country Link
US (1) US12496316B2 (https=)
EP (1) EP3641793A1 (https=)
JP (1) JP7343123B2 (https=)
KR (1) KR20200017516A (https=)
CN (1) CN111107858A (https=)
AU (1) AU2018288653A1 (https=)
CA (1) CA3067354A1 (https=)
IL (1) IL271395A (https=)
SG (1) SG11201912209UA (https=)
TW (1) TW201919664A (https=)
WO (1) WO2018236680A1 (https=)
ZA (1) ZA201908451B (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2023540096A (ja) 2020-09-08 2023-09-21 ロングエバーオン インコーポレイテッド アロジェニック間葉系幹細胞によるアルツハイマー病の治療
CN117999082A (zh) 2021-07-26 2024-05-07 美商生命科学有限公司 间充质干细胞在治疗青少年左心发育不良综合征中的用途
AU2022343620A1 (en) 2021-09-10 2024-01-18 Longeveron Inc. Treatment of aging frailty comprising administering bone marrow derived mesenchymal stem cells
KR102762783B1 (ko) * 2022-01-21 2025-02-05 고현서 심리 프로파일에 따른 행동 습관 제공 방법, 서버, 저장 매체 및 디바이스
WO2025137077A1 (en) 2023-12-19 2025-06-26 Longeveron, Inc. Improved brain architecture and biomarkers in alzheimer's disease with mesenchymal stem cells
WO2025199451A2 (en) 2024-03-21 2025-09-25 Longeveron Inc. Mmp-14 potency assay for mesenchymal stem cells

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL120266A (en) 1996-02-28 2005-05-17 Pfizer Use of estrogen antagonists and estrogen agonists in the preparation of medicaments for inhibiting pathological conditions
WO2007149548A2 (en) * 2006-06-22 2007-12-27 Medistem Laboratories, Inc. Treatment of erectile dysfunction by stem cell therapy
WO2010021996A1 (en) * 2008-08-18 2010-02-25 Junta De Beneficiencia De Guayaquil Treatment of injuries to the central nervous system
US8808688B2 (en) * 2009-10-06 2014-08-19 National University Corporation Nagoya University Cell preparation for erectile dysfunction or sensory disorders of the lower urinary tract containing adipose tissue derived mesenchymal stem cells
WO2013173694A2 (en) * 2012-05-18 2013-11-21 The Cooper Health System A method of restoring endothelial/smooth muscle architecture and cell signaling pathways to sexual organs
EA202190962A2 (ru) * 2014-05-30 2022-02-28 Оникс Терапьютикс, Инк. Уровни экспрессии иммуноглобулинов в качестве биологического маркера для реакции на ингибитор протеасом
CN105055450A (zh) * 2015-02-13 2015-11-18 中国福利会国际和平妇幼保健院 人宫内膜干细胞在制备治疗卵巢早衰的药物中的应用

Also Published As

Publication number Publication date
JP2020524179A (ja) 2020-08-13
US12496316B2 (en) 2025-12-16
EP3641793A1 (en) 2020-04-29
CA3067354A1 (en) 2018-12-27
TW201919664A (zh) 2019-06-01
CN111107858A (zh) 2020-05-05
AU2018288653A1 (en) 2020-01-16
ZA201908451B (en) 2021-05-26
SG11201912209UA (en) 2020-01-30
IL271395A (en) 2020-01-30
WO2018236680A1 (en) 2018-12-27
US20200129558A1 (en) 2020-04-30
JP7343123B2 (ja) 2023-09-12

Similar Documents

Publication Publication Date Title
KR20200017516A (ko) 성적 기능장애의 치료 및 성적 삶의 질의 향상
Yin et al. Adipose tissue-derived mesenchymal stem cells differentiated into hepatocyte-like cells in vivo and in vitro
DK2744892T3 (en) THERAPEUTICS USING FAT CELLS AND CELL SECRETIONS
KR102805246B1 (ko) 수명 및 건강수명을 연장시키기 위한 제제
KR20140040696A (ko) 간엽줄기세포 및 면역조절 t 세포를 유효성분으로 포함하는 면역질환의 예방 또는 치료용 세포치료제 조성물
KR102895422B1 (ko) 세포성 및 체액성 면역을 도출하기 위한 인간 중간엽 줄기 세포의 사용 방법
EP3299451B1 (en) Methods of using adipose tissue-derived cells in the treatment of raynaud's phenomenon
US8795632B2 (en) Disease animal model for chronic pain
Leary et al. Multiple sclerosis and demyelinating diseases
KR20210148958A (ko) 치아 주변조직 유래 다분화능 줄기세포를 포함하는 비만 또는 비알코올성 지방간의 예방 또는 치료용 약학적 조성물
Majdi et al. New facts about ovarian stem cells: the origin and the fate
JP2023002772A (ja) 脂肪細胞および細胞分泌物を使用する治療
Al-Suhaimi et al. Adrenal glands, pineal gland, and the circadian rhythm: structure and physiology
EP3549591A1 (en) Adipose-derived mesenchymal stem cells for stomatitis treatment
AU2015252071B2 (en) Systemic, allogenic stem cell therapies for treatment of diseases in animals
US20240065980A1 (en) Acellular compositions and methods
Shahid In vitro modelling and treatment of laminitis using equine stem cells
Protogerou et al. Stem cell therapy for erectile dysfunction: preliminary results from a single-center pilot study in Greece
Chalen Paredes Nicotinic regulation of hematopoiesis
US20200353006A1 (en) Pharmaceutical composition for treating cardiac hypertrophy
HK40109512A (zh) 使用人类间充质干细胞以实现细胞免疫及体液免疫的方法
JPWO2011049200A1 (ja) 掻痒抑制剤
HK40015513A (en) Therapeutics using adipose cells and cell secretions

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

R18-X000 Changes to party contact information recorded

St.27 status event code: A-3-3-R10-R18-oth-X000

R18-X000 Changes to party contact information recorded

St.27 status event code: A-3-3-R10-R18-oth-X000

PC1202 Submission of document of withdrawal before decision of registration

St.27 status event code: N-1-6-B10-B11-nap-PC1202